FREE Daily Stock Alerts From Stock-PR.com
Cleantech Transit Inc. (OTCPK:CLNO)
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project can generate shareholder returns as well benefit the Company's manufacturing clients worldwide. Cleantech Transit Inc. is in the business of producing and conserving power. It produces and sells clean electricity globally, with a focus on sustainable energies using renewable resources such as Geothermal, Solar and Wind.
Biomass is biological material derived from living, or recently living organisms. In the context of biomass for energy this is often used to mean plant based material, but biomass can equally apply to both animal and vegetable derived material. Biomass is an important source of energy and the most important fuel worldwide after coal, oil, and natural gas. Bio-energy, which is derived from biomass, is expected to be a pivotal resource which will contribute to global sustainable development.
Cleantech Transit Inc. is pleased to provide additional details after achieving success on the 500 KW facilities and successfully moving past the interconnection testing stage.
Coming on the recent success at the 500KW facility in Merced, California this poises Phoenix Energy to become a leading developer of renewable biomass distributed generation plants that utilize local resources for local energy.
Cleantech will be providing details on the expecting closing date of its initial investment into Phoenix Energy in the coming weeks.
Please visit Cleantech Transit, Inc. website www.cleantechtransitinc.com.
Power3 Medical Products, Inc. (OTC:PWRM)
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroProÂ®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
BC-SeraPro™ is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient's serum sample is compared to the Power3 Medical Products' patient database. Statistical analysis by linear discriminant function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis of the patient sample. Probability score is ranged from 0.0 to 1.0. Results of the BC-SeraPro™ test should not be considered a standalone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.
Like other types of breast cancer, medullary carcinoma may not cause any symptoms at first. Over time, a lump can form, and it may be soft and fleshy or somewhat firm to the touch. Most medullary carcinomas are small - less than 2 cm in size. Medullary carcinoma also may cause pain, swelling, redness, or tenderness in the breast.
Please visit Power3 Medical Products, Inc website http://www.power3medical.com.
Nexen Inc. (NYSE:NXY) announced that Marvin Romanow, President and CEO, will present at the following investor conference: CAPP Global Investment Symposium - Calgary, Alberta. Monday, June 13, 2011 at 8:50 am Mountain Time (10:50 am Eastern Time). We invite you to visit our website at www.nexeninc.com to view a live webcast of Marvin's presentation. The webcast will be archived under the Investors section of our website.
Nexen Inc. operates as an independent energy company worldwide. Its Oil and Gas segment explores for, develops, and produces crude oil, natural gas, and related products. This segment primarily operates onshore in Yemen and Canada, and offshore in the U.S. Gulf of Mexico and the U.K. North Sea, as well as in Colombia, offshore West Africa, and Norway.
3M Co. (NYSE:MMM) announced that it has received the 'Best Innovator' award in Germany for its best-in-class innovation management and corporate venturing. The award honors 3M for the unique way it identifies innovative start-ups and entrepreneurs with game-changing technologies and novel business models to bring new-to-3M business to the company for long lasting growth. The award, given under the patronage of the German Federal Ministry of Economics and Technology every year by A.T. Kearney, a global strategy consulting firm, and Wirtschaftswoche magazine, recognizes the best innovators in nine different industry sectors. A similar award is presented in countries throughout the world. This is the first year for the corporate venturing category.
3M Company, together with subsidiaries, operates as a diversified technology company worldwide. The company was founded in 1902 and is based in St. Paul, Minnesota.
CarMax Inc. (NYSE:KMX) announced the webcast and/or conference call access information for upcoming events. June 22, 2011 - First Quarter Fiscal 2012 Earnings Conference Call. On June 22, CarMax will release sales and earnings for the first quarter ended May 31, 2011, and will host a conference call for investors at 9:00 a.m. ET. June 27, 2011 - CarMax Annual Meeting of Shareholders. The CarMax 2011 annual meeting of shareholders will be held on Monday, June 27, at the Richmond Marriott West Hotel in Glen Allen, Va., beginning at 1:00 p.m. ET. A live webcast of the meeting will be available at investor.carmax.com. The webcast replay will be available through July 27, 2011 and June 29, 2011 - Oppenheimer 11th Annual Consumer Conference. President and Chief Executive Officer Tom Folliard will present at the Oppenheimer 11th Annual Consumer Conference on June 29 at the Four Seasons Hotel in Boston. The presentation will begin at 1:40 p.m. ET. A live webcast of the presentation will be available at investor.carmax.com. The webcast replay will be available through July 29, 2011.
CarMax, a member of the Fortune 500 and the S&P 500 and one of the Fortune 2011 "100 Best Companies to Work For," is the nation's largest retailer of used cars. Headquartered in Richmond, Va., CarMax currently operates 105 used car superstores in 51 markets.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) anticipates receiving 5,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services for Cleantech Transit, Inc. (OTCPK:CLNO). Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup